Advanced Search Results For "RC666-701"

Publication Type: Academic Journal

Source(s): ESC Heart Failure, Vol 10, Iss 6, Pp 3398-3409 (2023)

Abstract: Abstract Aims Heart failure (HF) is a common cause of morbidity and mortality, related to a broad range of sociodemographic, lifestyle, cardiometabolic, and comorbidity risk factors, which may differ according to the presence of atherosclerotic cardiov...

Publication Type: Academic Journal

Source(s): ESC Heart Failure, Vol 10, Iss 6, Pp 3258-3275 (2023)

Abstract: Abstract Recently established heart failure therapies, including sodium glucose co‐transporter 2 inhibitors, angiotensin‐neprilysin inhibitors, and cardiac resynchronization therapy, have led to both clinical and structural improvements. Reverse remode...

Publication Type: Academic Journal

Source(s): ESC Heart Failure, Vol 10, Iss 6, Pp 3612-3621 (2023)

Abstract: Abstract Aims Heart failure (HF) and chronic obstructive pulmonary disease (COPD) are largely managed in primary care, but their intersection in terms of disease burden, healthcare utilization, and treatment is ill‐defined. Methods and results We exami...

Publication Type: Academic Journal

Source(s): ESC Heart Failure, Vol 10, Iss 6, Pp 3472-3482 (2023)

Abstract: Abstract Aims The present analysis from the multicentre prospective Altshock‐2 registry aims to better define clinical features, in‐hospital course, and management of cardiogenic shock complicating acutely decompensated heart failure (ADHF‐CS) as compa...

Publication Type: Academic Journal

Source(s): ESC Heart Failure, Vol 10, Iss 6, Pp 3373-3384 (2023)

Abstract: Abstract Aims Heart failure with reduced ejection fraction (HFrEF) is associated with excessive sympathetic and impaired parasympathetic activity. The Barostim Neo™ device is used for electronical baroreflex activation therapy (BAT) to counteract auton...

Publication Type: Academic Journal

Source(s): ESC Heart Failure, Vol 10, Iss 6, Pp 3352-3363 (2023)

Abstract: Abstract Aims The guideline‐directed medical therapy (GDMT) has been recommended for heart failure (HF) with reduced ejection fraction (HFrEF) based on the accumulating clinical evidence. However, it is difficult to implement all the trial‐proven medic...

Publication Type: Academic Journal

Source(s): ESC Heart Failure, Vol 10, Iss 6, Pp 3364-3372 (2023)

Abstract: Abstract Aims Malnutrition is prevalent among patients with heart failure (HF); however, the effects of coexisting malnutrition and frailty on prognosis are unknown. This study examines the impact of malnutrition and frailty on the prognosis of patient...

Publication Type: Academic Journal

Source(s): ESC Heart Failure, Vol 10, Iss 6, Pp 3385-3397 (2023)

Abstract: Abstract Aims Heart failure is a chronic progressive condition, with considerable burden on patients' quality of life and economic burden for the healthcare systems. Before the approval of empagliflozin, there were no proven effective treatments for pa...

Publication Type: Academic Journal

Source(s): ESC Heart Failure, Vol 10, Iss 6, Pp 3446-3453 (2023)

Abstract: Abstract Aims To improve telemonitoring strategies in heart failure patients, there is a need for novel non‐obtrusive sensors that monitor parameters closely related to intracardiac filling pressures. This proof‐of‐concept study aims to evaluate the re...

Publication Type: Academic Journal

Source(s): ESC Heart Failure, Vol 10, Iss 6, Pp 3677-3689 (2023)

Abstract: Abstract Aims The use of guideline‐directed medical therapy (GDMT) among patients with heart failure (HF) with reduced ejection fraction (HFrEF) remains suboptimal. The SMYRNA study aims to identify the clinical factors for the non‐use of GDMT and to d...